Kelly Leo Kevin reported grant involving 3,527 shares of Cycurion, Inc. at $0.00 for $0 on May 1, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
CEO and Director
CEO and Director
Filed Oct 2, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$0Shares × reported price
Shares traded
3,527Common Stock, $0.01 par value per share
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
59,850Direct
Trade date
May 1, 2026Grant
Filed
Oct 2, 2026, 4:01 PM ET154-day reporting delay
Accession
0000919574-26-006643Code A · Transaction 234169
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Aug 19, 2026Gift3,073$0.00$0Trade 234171
Sep 28, 2026Gift8,742$0.00$0Trade 234172
Dec 9, 2025Grant7,102$0.00$0Trade 234166
Dec 26, 2025Grant157$0.00$0Trade 234167
Apr 26, 2026Grant36,564$0.00$0Trade 234168
Jul 29, 2026Grant100,200$0.00$0Trade 234170
7 transaction rows in this filing. Joint filers share the same rows.

Filing warnings

Notes recorded with this filing
1 warning
delayed filingThe filing was reported 154 calendar days after the transaction date.

CYCU price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
CYCU · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago1w ago1d ago
Returns since7d −22%30d −37%90d180d1y

Footnotes in full

F1: Reflects the Reporting Person's beneficial ownership after giving effect to the Company's 1-for-30 reverse stock split, which became effective on October 27, 2025, and the Company's 1-for-8 reverse stock split, which became effective on August 28, 2026. All share amounts reported herein have been adjusted to reflect such reverse stock splits. F2: The reported shares were acquired pursuant to a restricted stock award. The issuance price was $23.52 per share. The shares vested on July 1, 2026, at which time the closing market price of the Company's common stock was $4.40 per share. F3: Represents shares acquired pursuant to the Company's special common stock dividend and distributed pro rata to stockholders of record. No consideration was paid by the Reporting Person for the acquisition of such shares. F4: The reported shares were acquired pursuant to a restricted stock award. The issuance price was $2.40 per share. The shares vested on July 29, 2026, at which time the closing market price of the Company's common stock was $2.40 per share.